News

Dr. Sanyal talks about the importance in having ongoing real-world data for NAFLD and NASH.

Between 1980 and 2019 in Spain, a total of 2914 deaths were attributable to SSc, with rates increasing in a 4-year period in the 1980s.

Investigators found that when assessing patients with sickle cell disease and neuropathic pain the TRPV1 receptor is a crucial component in the development of hypersensitivity and potential therapeutic benefit of capsaicin.

Changes in disease severity were not observed in patients treated with acupuncture or osteopathic medicine, though a reduction in topical corticosteroid use was recorded.

Patients who use cannabis for physical health and mental health had poorer health and mental health compared to those in the non-medicinal cannabis use only group.

Jennifer Green, MD, discusses the benefit of relatively new innovations including continuous glucose monitoring and smart insulin pens.

Though current use rates have declined since 2017, investigators believe more young adults are transitioning from experimental to habitual use.

Results from this AoU database study found that Black and Hispanic patients and individuals with physical disabilities were at an increased risk of tinea versicolor.

Reductions in pethidine and diclofenac use was also observed in patients treated with the topical ointment.

According to the most comprehensive assessment of worldwide contraceptive use, vast differences in the types of contraceptives that are utilized across regions and age groups were identified.

During follow-up, 2.6% of the patients were diagnosed with depression, while 32.1% were treated with antidepressants.

There was a positive correlation between parental burnout, emotional schemas, and insomnia or hypersomnia.

The worldwide burden of vision loss continues to climb, but there may be solutions with regards to better access to care and improved screening.

Participants defined their acne/acne scars as an “intruder and unwanted companion” in the The Letter to my Disease personification exercise.

The relationship between hours of electronic device use and psychological distress was not mediated by insomnia.

According to a new report from the CDC, as fatal drug overdoses increase across the board, the Black and Indigenous communities represent a significantly greater death rates.

Though transgender medicine has existed for over 100 years, physicians like Dr. Jackson Turbeville are still looking for opportunities to make healthcare more accessible and affordable for patients seeking treatment for a variety of dermatologic conditions.

Cannabis sleep aid use was also linked to increased cannabis dependence symptoms among students using cannabis over 1 year, as well as past-2-week binge drinking among students using alcohol and lifetime cigarette use.

A 19 year-old patient presented with an isolated non-traumatic spontaneous epidural hematoma (EDH), an extremely rare consequence of sickle cell disease.

Dr. David Rosmarin details the recent FDA approval of ruxolitinib cream for vitiligo and how the accessibility of the topical therapy could help the roughly one million patients in the US who can't access standard treatment.

The Duke expert reviews key strategies for starting and continuing care with the pivotal glycemic control agent.

This episode of DocTalk features 5 expert retina specialists discussing the top line data from the conference.

ALT fluctuations remained stable for patients with NAFLD throughout disease progression.

Benzodiazepines, eszopiclone, zolpidem, and zopiclone had higher efficacies than melatonin, ramelteon, and zaleplon for insomnia disorder.

Dr. Patrick Flume encourages clinicians to think a little differently when presented with a patient who has a chronic cough without an identifiable cause.

The efficacy of treating insomnia sustained throughout the 24-week postintervention follow-up period for the electroacupuncture treatment group.

Over 60% of patients in the second year of TENAYA and LUCERNE were on 16 week dosing in the faricimab group.

Dipeptidyl peptidase-4 inhibitors have been linked to cases of bullous pemphigoid across Japan, prompting investigators to suggest trying DPP-4i discontinuation followed by supportive care.